L O A D I N G
May 1, 2014

Dr. Charles Sawyers joins The Column Group as Science Partner

The Column Group announced the recruitment of Dr. Charles Sawyers to firm as Science Partner. Widely recognized for his translational work in the field of oncology, Dr. Sawyers is the recipient of numerous awards, including the Lasker Clinical Award for breakthroughs in the treatment of chronic myeloid leukemia. He has played a key role in the discovery and development of multiple approved drugs, including imatinib (Gleevec), dasatinib (Sprycel), and enzalutamide (Xtandi).